Literature DB >> 10761675

Posttraumatic stress disorder: a model of the longitudinal course and the role of risk factors.

A C McFarlane1.   

Abstract

Posttraumatic stress disorder (PTSD) differs from other anxiety disorders in that experience of a traumatic event is necessary for the onset of the disorder. The condition runs a longitudinal course, involving a series of transitional states, with progressive modification occurring with time. Notably, only a small percentage of people that experience trauma will develop PTSD. Risk factors, such as prior trauma, prior psychiatric history, family psychiatric history, peritraumatic dissociation, acute stress symptoms, the nature of the biological response, and autonomic hyperarousal, need to be considered when setting up models to predict the course of the condition. These risk factors influence vulnerability to the onset of PTSD and its spontaneous remission. In the majority of cases, PTSD is accompanied by another condition, such as major depression, an anxiety disorder, or substance abuse. This comorbidity can also complicate the course of the disorder and raises questions about the role of PTSD in other psychiatric conditions. This article reviews what is known about the emergence of PTSD following exposure to a traumatic event using data from clinical studies.

Entities:  

Mesh:

Year:  2000        PMID: 10761675

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  44 in total

1.  Prefrontal cortex long-term potentiation, but not long-term depression, is associated with the maintenance of extinction of learned fear in mice.

Authors:  Cyril Herry; Rene Garcia
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

Review 2.  Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.

Authors:  David H Epstein; Kenzie L Preston; Jane Stewart; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2006-09-22       Impact factor: 4.530

3.  Traumatic event re-exposure in injecting drug users.

Authors:  Jessica M Peirce; Ken Kolodner; Robert K Brooner; Michael S Kidorf
Journal:  J Urban Health       Date:  2012-02       Impact factor: 3.671

4.  Posttraumatic stress disorder symptoms and sleep in the daily lives of World Trade Center responders.

Authors:  Jessica R Dietch; Camilo J Ruggero; Keke Schuler; Daniel J Taylor; Benjamin J Luft; Roman Kotov
Journal:  J Occup Health Psychol       Date:  2019-06-17

5.  The role of coercion in the treatment of women with co-occurring disorders and histories of abuse.

Authors:  Colleen Clark; Marion Becker; Julienne Giard; Ruta Mazelis; Andrea Savage; Wendy Vogel
Journal:  J Behav Health Serv Res       Date:  2005 Apr-Jun       Impact factor: 1.505

6.  Does comorbid posttraumatic stress disorder affect the severity and course of psychotic major depressive disorder?

Authors:  Brandon A Gaudiano; Mark Zimmerman
Journal:  J Clin Psychiatry       Date:  2009-12-15       Impact factor: 4.384

7.  Altered hippocampal function before emotional trauma in rats susceptible to PTSD-like behaviors.

Authors:  Rebecca Nalloor; Kristopher M Bunting; Almira Vazdarjanova
Journal:  Neurobiol Learn Mem       Date:  2014-02-28       Impact factor: 2.877

8.  Psychosocial outcomes at 18 months after good neurological recovery from aneurysmal subarachnoid haemorrhage.

Authors:  J Powell; N Kitchen; J Heslin; R Greenwood
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

9.  Posttraumatic stress disorder in Manhattan, New York City, after the September 11th terrorist attacks.

Authors:  Sandro Galea; Heidi Resnick; Jennifer Ahern; Joel Gold; Michael Bucuvalas; Dean Kilpatrick; Jennifer Stuber; David Vlahov
Journal:  J Urban Health       Date:  2002-09       Impact factor: 3.671

10.  Severe Mental Illness and Acute Stress: A Study of Service Utilization in a Conflict Zone.

Authors:  Demian Halperin; Tal Levy; Sofia Avissar; Gabriel Schreiber
Journal:  Psychiatr Q       Date:  2017-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.